{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:49:11Z","timestamp":1791751751635,"version":"4.3.4"},"reference-count":46,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Aust N Z J Psychiatry"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p>Recent years have seen escalating media, public and scientific interest in psychedelic medicine. Australia and New Zealand have been late to this research; however, in the past 2\u2009years, rapid developments suggest that this is changing. Here, we argue for the need to critically review existing evidence in this field to guide future directions. We focus on (\u00b1)3,4-methylenedioxymethamphetamine-assisted psychotherapy for post-traumatic stress disorder, currently the most advanced area of clinical psychedelic research. Food and Drug Administration approval of this approach is likely in 2023, based on a series of promising findings. We provide a detailed overview of Phase 2 and 3 studies published to date. We identify several concerns related to this body of evidence, including methodological\/design limitations and broader factors \u2013 such as robust involvement of advocacy groups in research and reliance on non-government financing leading to simplistic public messaging \u2013 that compound the methodological issues identified. We propose steps for future improvement, including the need for large, high-quality, independent efficacy trials with design enhancements, effectiveness trials and for researchers to consider their own engagement with media and public messaging around these modalities. We argue that, notwithstanding promising findings to date, rigorous and dispassionate science is needed to move the field forward and safeguard the welfare of participants.<\/jats:p>","DOI":"10.1177\/00048674221127186","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T05:21:47Z","timestamp":1664256107000},"page":"476-481","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":15,"title":["MDMA-assisted psychotherapy for post-traumatic stress disorder: The devil is in the detail"],"prefix":"10.1177","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6718-0099","authenticated-orcid":false,"given":"Gillinder","family":"Bedi","sequence":"first","affiliation":[{"name":"Centre for Youth Mental Health, Research and Translation, The University of Melbourne, Parkvillle, VIC, Australia"},{"name":"Orygen, Research and Translation, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M","family":"Cotton","sequence":"additional","affiliation":[{"name":"Centre for Youth Mental Health, Research and Translation, The University of Melbourne, Parkvillle, VIC, Australia"},{"name":"Orygen, Research and Translation, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre A.","family":"Guerin","sequence":"additional","affiliation":[{"name":"Centre for Youth Mental Health, Research and Translation, The University of Melbourne, Parkvillle, VIC, Australia"},{"name":"Orygen, Research and Translation, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J","family":"Jackson","sequence":"additional","affiliation":[{"name":"Melbourne School of Psychological Sciences, The University of Melbourne, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"bibr1-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.08.003"},{"key":"bibr2-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1635-z"},{"key":"bibr3-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2008.10400637"},{"key":"bibr4-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2022.03.008"},{"key":"bibr5-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01524-1"},{"key":"bibr6-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1177\/00048674211032112"},{"key":"bibr7-00048674221127186","unstructured":"Dickinson J, Mugianis D (2021) Why mental health researchers are studying psychedelics all wrong. Salon, 6 March. https:\/\/www.salon.com\/2021\/03\/06\/why-mental-health-researchers-are-studying-psychedelics-all-wrong\/"},{"key":"bibr8-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2019.1606472"},{"key":"bibr9-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05710-w"},{"key":"bibr10-00048674221127186","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00650"},{"key":"bibr11-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1002\/jts.22479"},{"key":"bibr12-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2018.211"},{"key":"bibr13-00048674221127186","volume-title":"60 Minutes Way Out There","author":"Greenway N","year":"2020"},{"key":"bibr14-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.17060647"},{"key":"bibr15-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1177\/0004867418824018"},{"key":"bibr16-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2020-0980"},{"key":"bibr17-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05548-2"},{"key":"bibr18-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.05.003"},{"key":"bibr19-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2383-4"},{"key":"bibr20-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239997"},{"key":"bibr21-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01336-3."},{"key":"bibr22-00048674221127186","volume-title":"A Manual for MDMA-Assisted Psychotherapy in the Treatment of Post-Traumatic Stress Disorder","author":"Mithoefer MC","year":"2017"},{"key":"bibr23-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-019-05249-5"},{"key":"bibr24-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30135-4"},{"key":"bibr25-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110378371"},{"key":"bibr26-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112456611"},{"key":"bibr27-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1080\/20008198.2020.1840123"},{"key":"bibr28-00048674221127186","volume-title":"A Manual for Adherence Ratings of MDMA-Assisted Therapy for Treatment of Posttraumatic Stress Disorder, Version 6","author":"Multidisciplinary Association for Psychedelic Studies (MAPS)","year":"2021"},{"key":"bibr29-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2013.02.002"},{"key":"bibr30-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1933434."},{"key":"bibr31-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1177\/00048674221081763."},{"key":"bibr32-00048674221127186","volume-title":"Post-Traumatic Stress Disorder NICE Guideline (NG116)","author":"National Institute for Health and Care Excellence","year":"2018"},{"key":"bibr33-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109356"},{"key":"bibr34-00048674221127186","unstructured":"Noakes J (2019) Psychedelic renaissance: Could MDMA help with PTSD, depression and anxiety? The Guardian, 14 April. https:\/\/www.theguardian.com\/science\/2019\/apr\/14\/psychedelic-renaissance-could-mdma-help-with-ptsd-depression-and-anxiety"},{"key":"bibr35-00048674221127186","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2019.21.2\/dnutt"},{"key":"bibr36-00048674221127186","unstructured":"Nuwer R (2021) A Psychedelic Drug Passes a Big Test for PTSD Treatment. The New York Times, 3 May. https:\/\/www.nytimes.com\/2021\/05\/03\/health\/mdma-approval.html"},{"key":"bibr37-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112464827"},{"key":"bibr38-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118806297"},{"key":"bibr39-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1177\/0004867421998785."},{"key":"bibr40-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1002\/jts.22696"},{"key":"bibr41-00048674221127186","volume-title":"Mental Health, Draft Report","volume":"1","author":"Productivity Commission","year":"2020"},{"key":"bibr42-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675512"},{"key":"bibr43-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.16020225"},{"key":"bibr44-00048674221127186","volume-title":"2019 National Survey on Drug Use and Health Annual National Report","author":"SAMHSA","year":"2020"},{"key":"bibr45-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117691569"},{"key":"bibr46-00048674221127186","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117711712"}],"container-title":["Australian &amp; New Zealand Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00048674221127186","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00048674221127186","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00048674221127186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:56:49Z","timestamp":1777373809000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.sagepub.com\/doi\/10.1177\/00048674221127186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1177\/00048674221127186"],"URL":"https:\/\/doi.org\/10.1177\/00048674221127186","relation":{},"ISSN":["0004-8674","1440-1614"],"issn-type":[{"value":"0004-8674","type":"print"},{"value":"1440-1614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]}}}